These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 21618474)
41. Resolving self-association of a therapeutic antibody by formulation optimization and molecular approaches. Casaz P; Boucher E; Wollacott R; Pierce BG; Rivera R; Sedic M; Ozturk S; Thomas WD; Wang Y MAbs; 2014; 6(6):1533-9. PubMed ID: 25484044 [TBL] [Abstract][Full Text] [Related]
42. Engineering of single chain antibodies for solubility. Safdari Y Int Immunopharmacol; 2018 Feb; 55():86-97. PubMed ID: 29227825 [TBL] [Abstract][Full Text] [Related]
43. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation. Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199 [TBL] [Abstract][Full Text] [Related]
45. Engineering antibodies for biosensor technologies. Goodchild S; Love T; Hopkins N; Mayers C Adv Appl Microbiol; 2006; 58():185-226. PubMed ID: 16509447 [No Abstract] [Full Text] [Related]
46. Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway. Dincq S; Bosman F; Buyse MA; Degrieck R; Celis L; de Boer M; Van Doorsselaere V; Sablon E Protein Expr Purif; 2001 Jun; 22(1):11-24. PubMed ID: 11388794 [TBL] [Abstract][Full Text] [Related]
47. Two-dimensional fluorescence difference gel electrophoresis for comparison of affinity and non-affinity based downstream processing of recombinant monoclonal antibody. Grzeskowiak JK; Tscheliessnig A; Toh PC; Chusainow J; Lee YY; Wong N; Jungbauer A J Chromatogr A; 2009 Jun; 1216(24):4902-12. PubMed ID: 19423113 [TBL] [Abstract][Full Text] [Related]
48. Improved affinity coupling for antibody microarrays: engineering of double-(His)6-tagged single framework recombinant antibody fragments. Steinhauer C; Wingren C; Khan F; He M; Taussig MJ; Borrebaeck CA Proteomics; 2006 Aug; 6(15):4227-34. PubMed ID: 16826567 [TBL] [Abstract][Full Text] [Related]
49. Novel antibody specificities targeting glycoprotein B of cytomegalovirus identified by molecular library technology. Axelsson F; Persson J; Moreau E; Côté MH; Lamarre A; Ohlin M N Biotechnol; 2009 Sep; 25(6):429-36. PubMed ID: 19464399 [TBL] [Abstract][Full Text] [Related]
50. Clarification technologies for monoclonal antibody manufacturing processes: Current state and future perspectives. Singh N; Arunkumar A; Chollangi S; Tan ZG; Borys M; Li ZJ Biotechnol Bioeng; 2016 Apr; 113(4):698-716. PubMed ID: 26302443 [TBL] [Abstract][Full Text] [Related]
51. Design and manufacture of monoclonal antibodies for radioimmunotherapy. Hale G; Berrie E; Bird P Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):258-66. PubMed ID: 15640789 [TBL] [Abstract][Full Text] [Related]
52. Scale-up of monoclonal antibody purification processes. Aldington S; Bonnerjea J J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):64-78. PubMed ID: 17224311 [TBL] [Abstract][Full Text] [Related]
54. Improving the stability of an antibody variable fragment by a combination of knowledge-based approaches: validation and mechanisms. Monsellier E; Bedouelle H J Mol Biol; 2006 Sep; 362(3):580-93. PubMed ID: 16926023 [TBL] [Abstract][Full Text] [Related]
55. Mass spectrometry to describe product and contaminant adsorption properties for bioprocess development. Berrill A; Ho SV; Bracewell DG Biotechnol Bioeng; 2011 Aug; 108(8):1862-71. PubMed ID: 21351073 [TBL] [Abstract][Full Text] [Related]
56. Mechanisms of unintended amino acid sequence changes in recombinant monoclonal antibodies expressed in Chinese Hamster Ovary (CHO) cells. Guo D; Gao A; Michels DA; Feeney L; Eng M; Chan B; Laird MW; Zhang B; Yu XC; Joly J; Snedecor B; Shen A Biotechnol Bioeng; 2010 Sep; 107(1):163-71. PubMed ID: 20506532 [TBL] [Abstract][Full Text] [Related]
57. Engineering of a broad-specificity antibody: detection of eight fluoroquinolone antibiotics simultaneously. Leivo J; Chappuis C; Lamminmäki U; Lövgren T; Vehniäinen M Anal Biochem; 2011 Feb; 409(1):14-21. PubMed ID: 20920457 [TBL] [Abstract][Full Text] [Related]
58. Design of humanized antibodies: from anti-Tac to Zenapax. Tsurushita N; Hinton PR; Kumar S Methods; 2005 May; 36(1):69-83. PubMed ID: 15848076 [TBL] [Abstract][Full Text] [Related]